Literature DB >> 28778764

Production of a bioactive unnatural ginsenoside by metabolically engineered yeasts based on a new UDP-glycosyltransferase from Bacillus subtilis.

Huichao Liang1, Zongfeng Hu1, Tingting Zhang1, Ting Gong1, Jingjing Chen1, Ping Zhu1, Yan Li1, Jinling Yang2.   

Abstract

Ginsenosides are the main bioactive constituents of Panax species, which are biosynthesized by glycosylation at C3-OH and/or C20-OH of protopanaxadiol (PPD), C6-OH and/or C20-OH of protopanaxatriol (PPT). The C12-glycosylated ginsenosides have scarcely been identified from Panax species. The C12-glycosylated ginsenosides produced from PPD by chemical semi-synthesis have been reported to exhibit higher cytotoxicity than the natural ginsenosides. However, the chemical semi-synthesis approach is not practical due to its complexity and high cost. In our study, a new UDP-glycosyltransferase UGT109A1 was identified from Bacillus subtilis. This enzyme transferred a glucose moiety to C3-OH and C20-OH of dammarenediol-II (DM), C3-OH and C12-OH of PPD and PPT respectively to produce the unnatural ginsenosides-O-Glc-DM, 3β,20S-Di-O-Glc-DM, 3β,12β-Di-O-Glc-PPD and 3β,12β-Di-O-Glc-PPT. Among these unnatural ginsenosides, 3β,12β-Di-O-Glc-PPT is a new compound which has never been reported before. The anti-cancer activities of these unnatural ginsenosides were evaluated in vitro and in vivo. 3β,12β-Di-O-Glc-PPD exhibited higher anti-lung cancer activity than Rg3, which is the most active natural ginsenoside against lung cancer. Finally, we constructed metabolically engineered yeasts to produce 3β,12β-Di-O-Glc-PPD by introducing the genes encoding B. subtilis UGT109A1, Panax ginseng dammarenediol-II synthase (DS), P. ginseng cytochrome P450-type protopanaxadiol synthase (PPDS) together with Arabidopsis thaliana NADPH-cytochrome P450 reductase (ATR1) into Saccharomyces cerevisiae INVSc1. The yield of 3β,12β-Di-O-Glc-PPD was increased from 6.17mg/L to 9.05mg/L by overexpressing tHMG1. Thus, this study has established an alternative route to produce the unnatural ginsenoside 3β,12β-Di-O-Glc-PPD by synthetic biology strategies, which provides a promising candidate for anti-cancer drug discovery.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bacillus subtilis; Ginsenoside biosynthesis; Metabolic engineering; Saccharomyces cerevisiae; UDP-glycosyltransferase

Mesh:

Substances:

Year:  2017        PMID: 28778764     DOI: 10.1016/j.ymben.2017.07.008

Source DB:  PubMed          Journal:  Metab Eng        ISSN: 1096-7176            Impact factor:   9.783


  13 in total

1.  Metabolic engineering of yeasts for green and sustainable production of bioactive ginsenosides F2 and 3β,20S-Di-O-Glc-DM.

Authors:  Fenglin Jiang; Chen Zhou; Yan Li; Haidong Deng; Ting Gong; Jingjing Chen; Tianjiao Chen; Jinling Yang; Ping Zhu
Journal:  Acta Pharm Sin B       Date:  2022-04-27       Impact factor: 14.903

2.  Genome-wide identification and expression analysis of glycosyltransferase gene family 1 in Quercus robur L.

Authors:  Jie Zhang; Li-Mei Lin; Wen-Wen Cheng; Xin Song; Yue-Hong Long; Zhao-Bin Xing
Journal:  J Appl Genet       Date:  2021-07-09       Impact factor: 3.240

3.  A highly versatile fungal glucosyltransferase for specific production of quercetin-7-O-β-D-glucoside and quercetin-3-O-β-D-glucoside in different hosts.

Authors:  Jie Ren; Wenzhu Tang; Caleb Don Barton; Owen M Price; Mark Wayne Mortensen; Alexandra Phillips; Banner Wald; Simon Elgin Hulme; Logan Powell Stanley; Joan Hevel; Jixun Zhan
Journal:  Appl Microbiol Biotechnol       Date:  2021-12-07       Impact factor: 4.813

4.  New Triterpenoid from Novel Triterpenoid 15-O-Glycosylation on Ganoderic Acid A by Intestinal Bacteria of Zebrafish.

Authors:  Te-Sheng Chang; Chien-Min Chiang; Tzi-Yuan Wang; Chun-Hsien Lee; Yu-Wen Lee; Jiumn-Yih Wu
Journal:  Molecules       Date:  2018-09-13       Impact factor: 4.411

5.  Uridine Diphosphate-Dependent Glycosyltransferases from Bacillus subtilis ATCC 6633 Catalyze the 15-O-Glycosylation of Ganoderic Acid A.

Authors:  Te-Sheng Chang; Jiumn-Yih Wu; Tzi-Yuan Wang; Kun-Yuan Wu; Chien-Min Chiang
Journal:  Int J Mol Sci       Date:  2018-11-05       Impact factor: 5.923

Review 6.  Progress on the Studies of the Key Enzymes of Ginsenoside Biosynthesis.

Authors:  Jin-Ling Yang; Zong-Feng Hu; Ting-Ting Zhang; An-Di Gu; Ting Gong; Ping Zhu
Journal:  Molecules       Date:  2018-03-06       Impact factor: 4.411

7.  The effects and mechanisms of a biosynthetic ginsenoside 3β,12β-Di-O-Glc-PPD on non-small cell lung cancer.

Authors:  Lu-Lu Huang; Mei Tang; Qian-Qian Du; Chun-Xia Liu; Chen Yan; Jin-Ling Yang; Yan Li
Journal:  Onco Targets Ther       Date:  2019-09-09       Impact factor: 4.147

8.  A New Triterpenoid Glucoside from a Novel Acidic Glycosylation of Ganoderic Acid A via Recombinant Glycosyltransferase of Bacillus subtilis.

Authors:  Te-Sheng Chang; Chien-Min Chiang; Yu-Han Kao; Jiumn-Yih Wu; Yu-Wei Wu; Tzi-Yuan Wang
Journal:  Molecules       Date:  2019-09-24       Impact factor: 4.411

9.  Enzymatic Synthesis of Unnatural Ginsenosides Using a Promiscuous UDP-Glucosyltransferase from Bacillus subtilis.

Authors:  Ting-Ting Zhang; Ting Gong; Zong-Feng Hu; An-Di Gu; Jin-Ling Yang; Ping Zhu
Journal:  Molecules       Date:  2018-10-28       Impact factor: 4.411

Review 10.  Recent Advances in the Metabolic Engineering of Yeasts for Ginsenoside Biosynthesis.

Authors:  Luan Luong Chu; Jake Adolf V Montecillo; Hanhong Bae
Journal:  Front Bioeng Biotechnol       Date:  2020-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.